Skip to main content
Figure 3 | Malaria Journal

Figure 3

From: Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria

Figure 3

Observed and predicted plasma concentration-time profiles (median values) of clindamycin in patients with sensitive response in Group-I (fosmidomycin 900 mg plus 300 clindamycin every 6 hours for 3 days) and Group-II (fosmidomycin 1800 mg plus 600 mg clindamycin every 12 hours). The curve represents simulated concentration-time profile based on the median concentrations in each group.

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us